Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Significant increases in neonatal abstinence syndrome (NAS) cases and widely disparate incidence rates among certain states have prompted CDC researchers to remind clinicians to appropriately prescribe opioid medication for pregnant women and screen women of reproductive age for opioid use disorder.
Neonatal abstinence syndrome affects infants who are exposed to opioids in utero. Shortly after birth, infants with NAS have drug withdrawal symptoms including tremors, increased muscle tone, high-pitched crying, seizures, feeding difficulties, and temperature instability.
Opiates Harm Newborns, Too. JAMA. 2016;316(12):1251. doi:10.1001/jama.2016.13476